• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性西酞普兰治疗后皮质而非海马的N-甲基-D-天冬氨酸受体的适应性变化。

Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment.

作者信息

Nowak G, Li Y, Paul I A

机构信息

Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson 39216-4505, USA.

出版信息

Eur J Pharmacol. 1996 Jan 4;295(1):75-85. doi: 10.1016/0014-2999(95)00585-4.

DOI:10.1016/0014-2999(95)00585-4
PMID:8925878
Abstract

Chronic treatment with citalopram produced a 6.2-fold reduction in the proportion of high affinity glycine-displaceable [3H]CGP-39653 binding sites and a 1.5-fold reduction in the potency of glycine to inhibit [3H]5,7-dichlorokynurenic acid binding in mouse cortex but not in hippocampus. Chronic citalopram also increased the aspartate concentration by 110% in cortex and 33% in hippocampus, and increased the glycine/threonine concentration by 33% in hippocampus. These results support the hypotheses that: (1) the adaptation of strychnine-insensitive glycine recognition sites and the allosteric coupling of the glycine and glutamate recognition sites are independently regulated by chronic antidepressant treatment; (2) chronic antidepressant administration induces regionally selective adaptation of the NMDA receptor complex; and (3) antidepressant-induced adaptation of the NMDA receptor complex may be mediated by regionally selective changes in excitatory amino acid concentration.

摘要

西酞普兰长期治疗使小鼠皮质中高亲和力甘氨酸置换型[3H]CGP - 39653结合位点的比例降低了6.2倍,使甘氨酸抑制[3H]5,7 - 二氯犬尿氨酸结合的效力降低了1.5倍,但在海马体中未出现这种情况。长期使用西酞普兰还使皮质中的天冬氨酸浓度增加了110%,海马体中的增加了33%,并使海马体中的甘氨酸/苏氨酸浓度增加了33%。这些结果支持以下假设:(1) 士的宁不敏感的甘氨酸识别位点的适应性以及甘氨酸和谷氨酸识别位点的变构偶联受慢性抗抑郁治疗的独立调节;(2) 慢性抗抑郁药给药诱导NMDA受体复合物的区域选择性适应性变化;(3) 抗抑郁药诱导的NMDA受体复合物适应性变化可能由兴奋性氨基酸浓度的区域选择性变化介导。

相似文献

1
Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment.慢性西酞普兰治疗后皮质而非海马的N-甲基-D-天冬氨酸受体的适应性变化。
Eur J Pharmacol. 1996 Jan 4;295(1):75-85. doi: 10.1016/0014-2999(95)00585-4.
2
Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors.通过特异性血清素再摄取抑制剂的长期治疗对皮质NMDA受体的适应性调节
Eur J Pharmacol. 1998 Jan 26;342(2-3):367-70. doi: 10.1016/s0014-2999(97)01589-6.
3
A partial agonist model used in the allosteric modulation of the NMDA receptor.一种用于NMDA受体变构调节的部分激动剂模型。
Eur J Pharmacol. 1997 Jun 11;328(2-3):255-63. doi: 10.1016/s0014-2999(97)83053-1.
4
Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine.慢性电惊厥休克或丙咪嗪处理后大鼠皮层中N-甲基-D-天冬氨酸受体的适应性变化
Eur J Pharmacol. 1993 Nov 15;247(3):305-11. doi: 10.1016/0922-4106(93)90199-j.
5
Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.通过配体结合以及大鼠脑中[3H]-CGP 39653的定量放射自显影区分区域不同的N-甲基-D-天冬氨酸受体
Br J Pharmacol. 1996 Nov;119(5):819-28. doi: 10.1111/j.1476-5381.1996.tb15746.x.
6
Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims.自杀受害者额叶皮质中N-甲基-D-天冬氨酸(NMDA)受体复合物的改变。
Brain Res. 1995 Mar 27;675(1-2):157-64. doi: 10.1016/0006-8993(95)00057-w.
7
Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.慢性抗抑郁治疗后N-甲基-D-天冬氨酸受体复合物的适应性变化
J Pharmacol Exp Ther. 1994 Apr;269(1):95-102.
8
Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.慢性给予丙咪嗪和1-氨基环丙烷羧酸后N-甲基-D-天冬氨酸受体复合物的适应性变化。
J Pharmacol Exp Ther. 1993 Jun;265(3):1380-6.
9
Does interaction between zinc and glutamate system play a significant role in the mechanism of antidepressant action?锌与谷氨酸系统之间的相互作用在抗抑郁作用机制中是否起重要作用?
Acta Pol Pharm. 2001 Jan-Feb;58(1):73-5.
10
Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.对大鼠脑N-甲基-D-天冬氨酸受体甘氨酸位点具有更高亲和力和选择性的犬尿氨酸类似物。
Mol Pharmacol. 1992 May;41(5):914-22.

引用本文的文献

1
A scientometric analysis of research on the role of NMDA receptor in the treatment of depression.NMDA受体在抑郁症治疗中作用的研究的科学计量学分析
Front Pharmacol. 2024 Jun 21;15:1394730. doi: 10.3389/fphar.2024.1394730. eCollection 2024.
2
Habenula as a Possible Target for Treatment-Resistant Depression Phenotype in Wistar Kyoto Rats.缰核作为 Wistar Kyoto 大鼠治疗抵抗性抑郁表型的可能靶点。
Mol Neurobiol. 2023 Feb;60(2):643-654. doi: 10.1007/s12035-022-03103-y. Epub 2022 Nov 8.
3
Genetic variables of the glutamatergic system associated with treatment-resistant depression: A review of the literature.
与难治性抑郁症相关的谷氨酸能系统的遗传变量:文献综述
World J Psychiatry. 2022 Jul 19;12(7):884-896. doi: 10.5498/wjp.v12.i7.884.
4
Brain NMDA Receptors in Schizophrenia and Depression.精神分裂症和抑郁症中的脑 NMDA 受体。
Biomolecules. 2020 Jun 23;10(6):947. doi: 10.3390/biom10060947.
5
Mechanisms of ketamine action as an antidepressant.氯胺酮作为抗抑郁药的作用机制。
Mol Psychiatry. 2018 Apr;23(4):801-811. doi: 10.1038/mp.2017.255. Epub 2018 Mar 13.
6
Convergent Mechanisms Underlying Rapid Antidepressant Action.快速抗抑郁作用的潜在汇聚机制。
CNS Drugs. 2018 Mar;32(3):197-227. doi: 10.1007/s40263-018-0492-x.
7
The role of GRIK4 gene in treatment-resistant depression.GRIK4基因在难治性抑郁症中的作用。
Genet Res (Camb). 2015 Jul 3;97:e14. doi: 10.1017/S0016672315000142.
8
GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine.含GluN2B的N-甲基-D-天冬氨酸受体调节抑郁样行为,并且对氯胺酮的快速抗抑郁作用至关重要。
Elife. 2014 Oct 23;3:e03581. doi: 10.7554/eLife.03581.
9
Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.抗抑郁药的药物遗传学:当前的临床实践和未来方向。
Pharmacogenomics. 2012 Mar;13(4):441-64. doi: 10.2217/pgs.12.1.
10
Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.增强突触可塑性和细胞恢复力以开发针对情绪障碍的新型、改良疗法。
Dialogues Clin Neurosci. 2002 Mar;4(1):73-92. doi: 10.31887/DCNS.2002.4.1/jquiroz.